Dosjebro, Sweden

Pär Ingemar Johansson

This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Rigshospitalet, Endothel Pharma Aps. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pär Ingemar Johansson. Retrieved from https://idiyas.com/inventor/pär-ingemar-johansson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 40.0

 

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Pär Ingemar Johansson: Innovator in Medical Treatments

Introduction

Pär Ingemar Johansson is a notable inventor based in Dösjebro, Sweden. He has made significant contributions to the field of medicine, particularly in the treatment of critically ill patients. With a total of 5 patents, Johansson's work focuses on innovative medical compositions and methods.

Latest Patents

Johansson's latest patents include a composition comprising prostacyclin and/or analogues thereof for the treatment of acute critically ill patients. This includes the use of prostacyclin or an analogue for a new medical indication, specifically targeting patients with systemic endothelial damage. His patents also detail a biomarker for identifying individuals with this new medical indication, along with a method for identifying such indications.

Career Highlights

Throughout his career, Johansson has worked with reputable institutions such as Rigshospitalet and Endothel Pharma ApS. His experience in these organizations has allowed him to develop and refine his innovative ideas in medical treatments.

Collaborations

Johansson has collaborated with notable colleagues, including Sisse Rye Ostrowski and Philip E. Hansen. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Pär Ingemar Johansson's contributions to medical innovation highlight his dedication to improving patient care for critically ill individuals. His work continues to influence the medical field and offers hope for new treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…